News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
376,357 Results
Type
Article (25807)
Company Profile (71)
Press Release (350479)
Section
Business (104333)
Career Advice (455)
Deals (16883)
Drug Delivery (49)
Drug Development (47592)
Employer Resources (48)
FDA (12232)
Job Trends (8430)
News (185987)
Policy (19415)
Tag
Academia (1734)
Alliances (26634)
Alzheimer's disease (738)
Approvals (12237)
Artificial intelligence (101)
Bankruptcy (136)
Best Places to Work (6873)
Breast cancer (132)
Cancer (890)
Cardiovascular disease (78)
Career advice (415)
Cell therapy (144)
Clinical research (39713)
Collaboration (266)
Compensation (63)
COVID-19 (1462)
C-suite (64)
Data (960)
Diabetes (111)
Diagnostics (3389)
Earnings (36130)
Events (50865)
Executive appointments (250)
FDA (12783)
Funding (232)
Gene therapy (79)
GLP-1 (339)
Government (2999)
Healthcare (12167)
Infectious disease (1513)
Inflammatory bowel disease (67)
IPO (6993)
Job creations (1840)
Job search strategy (384)
Layoffs (154)
Legal (3629)
Lung cancer (149)
Lymphoma (63)
Manufacturing (80)
Medical device (12740)
Medtech (12743)
Mergers & acquisitions (10008)
Metabolic disorders (299)
Neuroscience (937)
NextGen Class of 2024 (3928)
Non-profit (2823)
Northern California (889)
Obesity (174)
Opinion (65)
Parkinson's disease (59)
Patents (64)
People (34233)
Phase I (11368)
Phase II (17200)
Phase III (14120)
Pipeline (292)
Postmarket research (1670)
Preclinical (3558)
Radiopharmaceuticals (157)
Rare diseases (123)
Real estate (2845)
Regulatory (13803)
Research institute (1599)
Southern California (763)
Startups (2118)
United States (8563)
Vaccines (299)
Weight loss (125)
Date
Today (19)
Last 7 days (42)
Last 30 days (1214)
Last 365 days (19881)
2024 (19881)
2023 (22763)
2022 (30708)
2021 (33016)
2020 (32228)
2019 (28455)
2018 (21845)
2017 (18919)
2016 (18122)
2015 (21225)
2014 (16039)
2013 (13253)
2012 (14362)
2011 (14664)
2010 (13219)
Location
Africa (356)
Arizona (93)
Asia (24186)
Australia (3821)
California (1959)
Canada (882)
China (221)
Colorado (110)
Connecticut (114)
Delaware (66)
Europe (47171)
Florida (331)
Georgia (85)
Illinois (264)
Indiana (159)
Japan (59)
Kansas (67)
Maryland (463)
Massachusetts (1415)
Michigan (77)
Minnesota (196)
New Jersey (721)
New York (606)
North Carolina (424)
Northern California (889)
Ohio (92)
Pennsylvania (575)
South America (519)
Southern California (763)
Texas (332)
Utah (63)
Washington State (161)
376,357 Results for "tides medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Vivani Medical to Present at TIDES Conference 2024
Vivani Medical, Inc. today announced that it will present at the TIDES Conference 2024 at 4:30 p.m. ET at the Hynes Convention Center in Boston on Friday, May 17.
May 9, 2024
·
4 min read
Press Releases
Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics
November 12, 2024
·
8 min read
Press Releases
Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting
October 24, 2024
·
7 min read
Genetown
EnPlusOne Biosciences to Unveil Advances in Enzymatic Synthesis of RNA at TIDES 2024, Leading Conference on Oligonucleotides and Peptide Therapeutics
EnPlusOne Biosciences, Inc. announced that co-founder and Chief Scientific Officer Jonathan Rittichier, PhD, will be presenting recent advances in the company’s ezRNA™ platform at TIDES USA 2024 in Boston on Thursday, May 16, 2024 at 9 am.
May 14, 2024
·
2 min read
Genetown
Alltrna Announces Presentations at ASGCT 27th Annual Meeting and TIDES USA 2024
Alltrna today announced a poster presentation at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting taking place May 7-11 in Baltimore and a talk and two poster presentations at TIDES USA 2024 taking place May 14-17 digitally and in-person in Boston.
April 22, 2024
·
2 min read
YolTech Therapeutics to Showcase Breakthroughs in in vivo Gene Editing at TIDES Asia 2024
YolTech Therapeutics, a biotech company pioneering in in vivo gene editing therapies, today announced participation in TIDES Asia 2024, March 19th to 21st, 2024, at the Westin Miyako Kyoto in Kyoto, Japan.
March 13, 2024
·
1 min read
Pharm Country
New In Vitro Data Showing Matinas BioPharma’s LNC Platform Delivering Small Oligonucleotides Presented at TIDES USA 2024
Matinas BioPharma Holdings, Inc. announces new in vitro data showing the use of LNCs for the delivery of small oligonucleotides was presented yesterday in a poster session at TIDES USA 2024: Oligonucleotide & Peptide Therapeutics, a hybrid in-person and virtual conference underway in Boston.
May 16, 2024
·
5 min read
Biotech Bay
Codexis to Present Update on ECO Synthesis™ Platform at TIDES Europe
Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced a presentation highlighting the role of an enzymatic approach to support RNA-based therapeutics manufacturing at the TIDES Europe annual meeting taking place in Amsterdam, Netherlands and virtually October 30-November 1, 2023.
October 26, 2023
·
5 min read
Biotech Bay
Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting
Codexis, Inc., a leading enzyme engineering company, announced it has successfully synthesized an oligonucleotide via an enzymatic route to support RNA-based therapeutics manufacturing.
May 14, 2024
·
9 min read
Genetown
Aktis Oncology Announces Presentation at the Oligonucleotide & Peptide Therapeutics (TIDES USA) Conference 2024
Aktis Oncology, a biotechnology company discovering and developing novel targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, announces an oral presentation at the Oligonucleotide & Peptide Therapeutics Conference 2024, being held May 14-17, 2024, in Boston, Mass. and virtually.
May 13, 2024
·
1 min read
1 of 37,636
Next
